George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.00
Bid: 56.00
Ask: 56.40
Change: -0.30 (-0.53%)
Spread: 0.40 (0.714%)
Open: 56.00
High: 56.00
Low: 56.00
Prev. Close: 56.50
AXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Accsys Trading Update

26 Jan 2023 07:00

RNS Number : 8978N
Accsys Technologies PLC
26 January 2023
 

AIM: AXS

Euronext Amsterdam: AXS

 

26 January 2023

 

Accsys Technologies PLC

("Accsys", the "Group" or the "Company")

 

Trading update for the nine months ended 31 December 2022

Strong growth in the third quarter to 31 December 2022 reflects demand for our products, greater capacity at our Arnhem plant and pricing power for our portfolio of sustainable wood building products.

 

Accsys, the fast-growing and eco-friendly company that combines chemistry and technology to create high performance, sustainable wood building products, today announces a trading update for the nine months ended 31 December 2022 ('nine months'), on an unaudited basis. Comparative percentage change figures in this statement reflect comparisons with the corresponding nine months in the prior financial year.  

 

9 months to Dec 2022

9 months to Dec 2021

% change

Total Group revenue

€109m

€83m

32%

Accoya® wood revenue

€97m

€72m

35%

Total sales m3

42,972

42,536

1%

Net (debt)

(€52m)

(€61m)1

1 Net debt as of 30 September 2022

Financial highlights

· Strong growth in Group revenue, up 32% to €109m, driven by higher production at Arnhem facility (production levels from Reactors 1-3 at capacity in Q3 and the new fourth reactor ('R4') ramping up) and further increases in average sale prices

· Accoya® sales volumes in Q3 (October to end December) were 19,015m3 versus total H1 FY23 volumes of 23,957m3 reflecting increased capacity at Arnhem from Reactors 1-3 returning to full production following the completion of R4 in September, new production from R4 and some unwinding of higher inventory (work in progress) levels. 

· Customer demand for Accoya® remains resilient, with a visible Q4 customer order book despite some slowdown in the broader construction industry. The higher average sales prices reflect price increases implemented in H1, plus a further small increase in Q3. In addition, we have continued to successfully manage the effect of volatile chemical raw material prices through the Energy Price Premium which increased in Q3, although this is expected to reduce in Q4 as European energy market indices subside.

· The combination of price increases and efficiency of operating at higher production volumes has enabled further progression in the profit per cubic metre of Accoya® sold in Q3.

· Net debt of €52m, represents a reduction of €9m compared to September 2022, reflecting the reduction in the NatWest loan balance resulting from the Tricoya® restructure announced on 2 November. Cash outflow resulting from a reduction in payables from the Hull project as it moved into the hold period in Q3 was partially offset by positive cash flow from the Accoya® business. While inventory balances remained higher than required due to the long lead times of previous commitments and delivery timings around holiday periods, these are expected to reduce by the year-end.

 

Continued good progress on strategic growth projects:

· Accoya® (Arnhem) plant - R4 expansion commenced commercial operation in September 2022 and performing well, with production now successfully ramping up over forecast two years.

· Accoya® USA JV - Construction of new 43,000m3 plant continues to progress well and remains on track to commence commercial operation by March 2024.

· Tricoya® (Hull) plant currently in an at least six-month hold period from November 2022:

The Board continues to assess the economics and capability of the plant and its potential returns on investment. 

In parallel, the Board is also evaluating funding options, as outlined in previous company announcements, which include discussions with potential third-party partners and contractors.

Verification of the final cost and time to complete the plant is ongoing, and while it is too early to give an exact figure, there are no indications that this will exceed the up to €35m previously identified by the Company.

The Board of Accsys continues to see the market potential of Tricoya® and will consider all relevant commercial factors in deciding whether or not to proceed with the Hull plant and if so, on what basis.

 

Management update

The Company is making good progress on the recruitment for a new Chief Executive and will issue an update in due course. The process to appoint the Chief Financial Officer is ongoing. To ensure continuity of management while that process concludes, the Board is pleased to announce that Will Rudge (Finance Director) will stay on for a further short period of time to support the Company.

 

Commenting on today's announcement, Rob Harris, Chief Executive of Accsys Technologies, said:

"I am pleased with our performance over the last three months. We have delivered strong revenue growth in our Accoya® business due to enhanced capacity from our Arnhem plant. Notwithstanding ongoing macro-economic uncertainty, our expectations for customer orders continue to provide confidence in demand and growth opportunities for both our market-leading products, Accoya® and Tricoya®. We remain on track for sales volumes in H2 to increase by 50% compared to H1 and, as a result, we continue to target our previously stated ambition of nearly doubling underlying EBITDA for the full year.''

Ends

For further information, please contact:

Accsys Technologies PLCKatharine Rycroft, Investor Relations

ir@accsysplc.com

Numis Securities (London) Oliver Hardy (NOMAD), Ben Stoop

+44 (0) 20 7260 1000

Investec Bank plc (London) Carlton Nelson, Alex Wright

ABN Amro (Amsterdam) Richard van Etten, Dennis van Helmond

+44 (0) 20 7597 5970

+31 20 344 2000

FTI Consulting (UK) Matthew O'Keeffe, Alex Le May

+44 (0) 20 3727 1340 

Off the Grid (The Netherlands) Frank Neervoort, Yvonne Derske

+31 681 734 236

 

Notes to editors:

 

Accsys (Accsys Technologies PLC) is a fast-growing business with a purpose: changing wood to change the world. The company combines chemistry, technology and ingenuity to make Accoya® wood and Tricoya® wood elements: high performance wood products that are extremely durable and stable, opening new opportunities for the built environment and giving the world a choice to build sustainably. Accsys transforms fast-growing, certified sustainable wood into building materials with an up to 50-year warranty, locking carbon stored in the wood into useful products for decades, with performance characteristics that match or better those of non-renewable, resource-depleting and polluting alternatives. Accsys is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'. Visit www.accsysplc.com 

Accoya® solid wood is sustainable, durable, and stable with exceptional performance, finish and sustainability. Accsys' proprietary acetylation process makes the wood more dimensionally stable and because it is no longer easily digestible, extremely durable. It is one of very few building materials to be Cradle to Cradle Certified™ at the Gold level, with a Platinum rating for Material Health, confirming that no harmful or toxic additives or chemicals are present to leach out into the environment. Primary applications for Accoya® wood include windows, doors, cladding and decking, where the combination of performance and sustainability benefits compete favorably against hardwoods, plastics, metals and concrete. Visit www.accoya.com

Tricoya® acetylated wood elements are produced for use in the fabrication of panel products such as medium density fibreboard (MDF). Panel products made with Tricoya® wood elements are truly durable and stable enough for use outdoors and in wet environments, unlocking new possibilities for design and construction. They have been lauded as the first major innovation in the wood composites industry in more than 30 years and bring the flexibility of traditional panel products and sustainability benefits of wood to a whole new range of applications. Visit www.tricoya.com

Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. 'Accsys' and 'Accsys Technologies' are trading names of Titan Wood Limited ("TWL"), a wholly-owned subsidiary of Accsys Technologies PLC. Accoya®, Tricoya® and the Trimarque Device are registered trademarks owned by TWL, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered brand trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBAMBTMTATTRJ
Date   Source Headline
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM
12th Dec 20237:00 amRNSDirectorate Change
27th Nov 20239:57 amRNSNotifiable Interest - De Engh B.V.
27th Nov 20239:33 amRNSNotifiable Interest – Teslin
24th Nov 202312:21 pmRNSNotifiable Interest – De Engh B.V.
21st Nov 20233:37 pmRNSResults of Capital Raise
21st Nov 20237:04 amRNSHalf-year Report
21st Nov 20237:00 amRNSIssue of Equity
20th Sep 20235:12 pmRNSResults of Annual General Meeting 2023
15th Sep 20233:54 pmRNSNotifiable Interest - De Engh
12th Sep 20237:00 amRNSDirectorate Change
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
1st Sep 20237:00 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSTrading Update
17th Aug 20235:01 pmRNSNotice of Annual General Meeting 2023
28th Jul 20237:00 amRNSDirector Interests and LTIP Awards
26th Jul 20237:00 amRNSDirectorate Appointment
21st Jul 20233:46 pmRNSAnnual Report and Financial Statements 2023
27th Jun 20237:00 amRNSPreliminary results for the year end 31 March 2023
19th Jun 202312:48 pmRNSChange of Registered Office
6th Jun 20237:00 amRNSDirectorate Update
12th May 202311:21 amRNSBlock Listing Application to AIM
3rd May 20237:00 amRNSTrading Update
4th Apr 20237:00 amRNSCEO Appointment
24th Mar 20237:00 amRNSDirectorate Appointments
2nd Mar 20236:00 pmRNSBlock Listing Six Monthly Return
2nd Mar 20236:00 pmRNSTotal Voting Rights
26th Jan 20237:00 amRNSAccsys Trading Update
15th Dec 20223:55 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSDirectorate Change
6th Dec 20223:43 pmRNSNotifiable Interest - De Engh
6th Dec 20223:36 pmRNSNotifiable Interest - Teslin Participaties
22nd Nov 20227:00 amRNSInterim Results for six months ended 30 Sept 2022
17th Nov 20222:58 pmRNSIssue of Equity
10th Nov 20224:37 pmRNSHolding(s) in Company
8th Nov 20225:09 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSUpdate on Tricoya – Consortium restructure
1st Nov 20224:12 pmRNSNotice of HY Results and Total Voting Rights
23rd Sep 20224:20 pmRNSResult of AGM
12th Sep 20227:00 amRNSAccsys Trading Update
23rd Aug 20224:49 pmRNSNotice of AGM
23rd Aug 20222:35 pmRNSBlock Listing Application to AIM
3rd Aug 20227:00 amRNSDirectorate Change
27th Jul 20225:56 pmRNSAnnual Report
12th Jul 202210:40 amRNSDirector Interests and LTIP Awards
12th Jul 202210:16 amRNSGrant of Awards under Accsys Deferred Bonus Plan
30th Jun 20227:00 amRNSPreliminary results for the year end 31 March 2022
10th Jun 20227:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.